Atara Biotherapeutics, Inc.
ATRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$85 | -$276 | -$228 | -$340 |
| Dep. & Amort. | $5 | $5 | $6 | $9 |
| Deferred Tax | $0 | $0 | $0 | $2 |
| Stock-Based Comp. | $27 | $45 | $54 | $54 |
| Change in WC | -$31 | $15 | -$61 | $53 |
| Other Non-Cash | $16 | $18 | -$40 | $2 |
| Operating Cash Flow | -$69 | -$193 | -$270 | -$221 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$1 | -$4 | -$11 |
| Net Acquisitions | $0 | $0 | $0 | -$33 |
| Inv. Purchases | -$20 | -$84 | -$181 | -$301 |
| Inv. Sales/Matur. | $29 | $209 | $293 | $334 |
| Other Inv. Act. | $0 | $0 | $95 | $33 |
| Investing Cash Flow | $9 | $124 | $203 | $22 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1 | -$1 | -$1 | -$0 |
| Stock Issued | $60 | $2 | $22 | $99 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $1 | $32 | $6 |
| Financing Cash Flow | $59 | $2 | $53 | $104 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1 | -$67 | -$14 | -$94 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $26 | $93 | $107 | $202 |
| End Cash | $25 | $26 | $93 | $107 |
| Free Cash Flow | -$69 | -$194 | -$275 | -$231 |